A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
- Status
- RECRUITING
- Phase
- PHASE2
Cohort Study Assessing the Treatment Strategy for High-Risk Myelodysplastic Syndromes in Patients Under 70
- Status
- UNKNOWN
- Phase
- N/A
A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts
- Status
- RECRUITING
- Phase
- PHASE2
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic γδ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
- Status
- RECRUITING
- Phase
- N/A
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
- Status
- RECRUITING
- Phase
- PHASE1
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
- Status
- TERMINATED
- Phase
- PHASE1
Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Biologically Focused Therapy of Treatment-Refractory MDS Patients
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients
- Status
- TERMINATED
- Phase
- PHASE2
Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- N/A